MwanzoSFOSF • OTCMKTS
add
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
Bei iliyotangulia
$ 1.70
Bei za mwaka
$ 1.50 - $ 2.24
Thamani ya kampuni katika soko
60.97B HKD
Wastani wa hisa zilizouzwa
35.00
Uwiano wa bei na mapato
-
Mgao wa faida
-
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CNY) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 10.45B | 12.30% |
Matumizi ya uendeshaji wa biashara | 4.11B | -4.30% |
Mapato halisi | 785.84M | 55.43% |
Kiwango cha faida halisi | 7.52 | 38.49% |
Mapato kwa kila hisa | — | — |
EBITDA | 1.60B | 229.39% |
Asilimia ya kodi ya mapato | 15.05% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CNY) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 15.63B | -1.12% |
Jumla ya mali | 115.26B | 4.06% |
Jumla ya dhima | 56.07B | 2.35% |
Jumla ya hisa | 59.19B | — |
hisa zilizosalia | 2.66B | — |
Uwiano wa bei na thamani | 0.10 | — |
Faida inayotokana na mali | 2.03% | — |
Faida inayotokana mtaji | 2.49% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CNY) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 785.84M | 55.43% |
Pesa kutokana na shughuli | 1.08B | 65.68% |
Pesa kutokana na uwekezaji | 210.24M | 122.80% |
Pesa kutokana na ufadhili | -1.59B | 11.34% |
Mabadiliko halisi ya pesa taslimu | -389.75M | 80.29% |
Mtiririko huru wa pesa | -2.97B | 27.05% |
Kuhusu
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1994
Tovuti
Wafanyakazi
39,309
